Free Trial

Caisse DE Depot ET Placement DU Quebec Invests $16.90 Million in Amdocs Limited $DOX

Amdocs logo with Computer and Technology background

Key Points

  • Caisse DE Depot ET Placement DU Quebec acquired 184,727 shares of Amdocs Limited, valued at approximately $16.9 million, representing a 0.16% stake in the company.
  • Multiple institutional investors, including Jane Street Group and Bahl & Gaynor Inc., have increased their holdings in Amdocs during the first quarter of the year, indicating strong institutional interest.
  • Analysts have generally rated Amdocs as a "Buy" with a consensus target price of $105.33, following recent positive earnings results that exceeded expectations, reporting $1.72 EPS.
  • MarketBeat previews the top five stocks to own by October 1st.

Caisse DE Depot ET Placement DU Quebec acquired a new stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 184,727 shares of the technology company's stock, valued at approximately $16,903,000. Caisse DE Depot ET Placement DU Quebec owned approximately 0.16% of Amdocs at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of DOX. Alyeska Investment Group L.P. grew its position in Amdocs by 86.8% during the 4th quarter. Alyeska Investment Group L.P. now owns 1,681,074 shares of the technology company's stock worth $143,127,000 after acquiring an additional 781,061 shares during the last quarter. American Century Companies Inc. grew its position in Amdocs by 23.5% during the 1st quarter. American Century Companies Inc. now owns 2,242,829 shares of the technology company's stock worth $205,219,000 after acquiring an additional 426,911 shares during the last quarter. Nuveen LLC bought a new position in Amdocs during the 1st quarter worth approximately $36,921,000. The Manufacturers Life Insurance Company grew its position in Amdocs by 2,489.0% during the 4th quarter. The Manufacturers Life Insurance Company now owns 376,383 shares of the technology company's stock worth $32,045,000 after acquiring an additional 361,845 shares during the last quarter. Finally, LSV Asset Management grew its position in Amdocs by 11.1% during the 1st quarter. LSV Asset Management now owns 3,180,501 shares of the technology company's stock worth $291,016,000 after acquiring an additional 317,412 shares during the last quarter. 92.02% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Wall Street Zen upgraded Amdocs from a "hold" rating to a "buy" rating in a research report on Sunday, August 10th. Wolfe Research assumed coverage on Amdocs in a research note on Tuesday, July 8th. They issued an "outperform" rating for the company. Four investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, Amdocs currently has an average rating of "Buy" and an average target price of $105.33.

Get Our Latest Report on DOX

Amdocs Stock Up 1.2%

Shares of DOX traded up $0.98 on Monday, reaching $85.57. The stock had a trading volume of 1,357,151 shares, compared to its average volume of 950,551. The firm has a market capitalization of $9.66 billion, a price-to-earnings ratio of 17.36, a price-to-earnings-growth ratio of 1.57 and a beta of 0.54. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.22 and a current ratio of 1.22. The company has a 50-day simple moving average of $88.52 and a 200-day simple moving average of $88.79. Amdocs Limited has a 12-month low of $78.61 and a 12-month high of $95.41.

Amdocs (NASDAQ:DOX - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The technology company reported $1.72 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.01. The business had revenue of $1.14 billion during the quarter, compared to analysts' expectations of $1.13 billion. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The firm's quarterly revenue was down 8.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.62 earnings per share. Sell-side analysts predict that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a dividend of $0.527 per share. The ex-dividend date is Tuesday, September 30th. This represents a $2.11 dividend on an annualized basis and a yield of 2.5%. Amdocs's payout ratio is presently 42.80%.

Amdocs Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Featured Articles

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Should You Invest $1,000 in Amdocs Right Now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines